Praxis Trial Results

2026-10-29

Analysts Express Conflicting Sentiments on Materials Stocks: FCX, RGLD, SHW

Goldman Sachs and UBS analysts issued conflicting ratings on major materials firms, recommending buys for Freeport-McMoRan and Royal Gold while holding Sherwin-Williams despite price target upside.

The Globe and Mail · 2026-10-29 12:45 UTC

2026-10-29

Analysts Offer Insights on Materials Companies: Elevra Lithium, Freeport-McMoRan and Sherwin-Williams

Analysts issued new ratings for key materials firms, assigning Strong Buy consensus to Elevra Lithium and Moderate Buy to Freeport-McMoRan and Sherwin-Williams.

The Globe and Mail · 2026-10-29 12:10 UTC · 2 media covered

2026-06-10

5 Best AI-Driven Biotech Stocks to Invest In

Praxis Precision Medicines is highlighted as a top AI-driven biotech investment despite a recent price target cut by BTIG, with analysts maintaining buy ratings based on its central nervous system the

Insider Monkey · 2026-06-10 08:39 UTC

Media coverage (3)

Analysts Express Conflicting Sentiments on Materials Stocks: FCX, RGLD, SHWThe Globe and Mail
Analysts Offer Insights on Materials Companies: Elevra Lithium, Freeport-McMoRan and Sherwin-WilliamsThe Globe and Mail
5 Best AI-Driven Biotech Stocks to Invest InInsider Monkey

Praxis Trial Results

Analysts Express Conflicting Sentiments on Materials Stocks: FCX, RGLD, SHW

Analysts Offer Insights on Materials Companies: Elevra Lithium, Freeport-McMoRan and Sherwin-Williams

5 Best AI-Driven Biotech Stocks to Invest In

Media coverage (3)

Related topics